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Summary
Introduction:  Superﬁcial  myxoﬁbrosarcomas  are  malignant  connective  tissue  tumors,  whose
very frequent  recurrence  inﬂuences  the  local  and  vital  prognosis.  Even  when  resection  seems
to be  macroscopically  complete  it  is  very  often  microscopically  contaminated.  The  aim  of  this
study was  to  evaluate  recurrence  in  relation  to  the  surgical  margins  and  to  compare,  when
possible,  tumor  size,  evaluated  clinically  and  macroscopically  by  the  pathologist.
Materials  and  methods:  This  was  a  single  center  study  of  21  patients,  mean  age  67  years  old,
treated for  superﬁcial  myxoﬁbrosarcoma.  The  number,  date  and  location  of  recurrence  were
collected  for  each  patient.  A  clinical  and  pathological  measurement  was  made  of  the  longest
axis of  the  tumor  in  each  case  of  recurrence.
Results:  Fifty-seven  percent  of  patients  presented  with  recurrent  tumors.  The  mean  number  of
recurrences  was  1.4  per  patient  (1—8).  The  surgical  margins  were  wide  in  four  cases,  marginal  in
two cases  and  incomplete/intralesional  in  15  other  patients  with  a  rate  of  recurrence  of  25,  50
and 67%  respectively.  The  size  evaluated  during  the  preoperative  clinical  examination  (14  cases)
was underestimated  by  a  mean  2.4  cm  compared  to  the  macroscopic  pathology  assessment.  The
 cases)  was  also  underestimated  by  a  mean  1.3  cm.preoperative  size  on  MRI  (5
Conclusion:  Superﬁcial  myxoﬁbrosarcomas  are  tumors  that  are  difﬁcult  to  resect  completely
because they  are  inﬁltrative,  a  feature  that  is  often  underestimated  before  surgery.  Surgical
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treatment  of  this  entity  requires  a  much  larger  surgical  margin  than  that  suggested  by  the
preoperative  clinical  and  MRI  evaluations.  In  case  of  incomplete  resection,  revision  scar  surgery
should systematically  be  performed.
Level  of  evidence:  Level  IV.  Retrospective  study.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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grade  1  tumors,  the  recurrent  tumor  was  one  grade  higherntroduction
uperﬁcial  myxoﬁbrosarcomas  are  malignant  connective  tis-
ue  tumors,  which  usually  progress  slowly  [1].  Nevertheless,
he  rate  of  recurrence  is  very  high  in  these  tumors,  inﬂu-
ncing  the  local  and  vital  prognosis.  Recurrence  is  usually
ocal  characterized  by  extension  along  the  fascias  and  the
ypodermal  passageways  around  the  nodule  [2,3].  Although
urgical  resection  may  seem  complete  to  the  surgeon  it
s  often  found  to  be  incomplete  by  the  pathologist.  One
ossible  explanation  is  that  the  size  of  the  tumor  is  under-
stimated  clinically  and  on  MRI  because  of  the  highly
nﬁltrative  and  poorly  differentiated  tumor  proliferation  in
djacent  subcutaneous  tissue.  It  is  therefore  difﬁcult  to  pre-
isely  deﬁne  the  extent  of  surgical  resection  that  will  be
ecessary  [4].
The  aim  of  this  study  was  to  evaluate  the  rate  of  recur-
ence  in  relation  to  the  surgical  margins  and  to  compare,
hen  possible,  the  size  of  the  tumor  measured  clinically  and
acroscopically  by  a  pathologist.  Because  this  was  a  ret-
ospective  study  we  could  not  measure  the  largest  axis  of
he  tumor  based  on  the  extent  of  tumoral  invasion  detected
n  microscopic  analysis,  which  is  the  usual  tumor  sampling
rocedure,  so  that  this  variable  could  not  be  precisely  deter-
ined.
aterials and methods
aterials
his  was  a  continuous  retrospective  series  of  patients
reated  for  superﬁcial  myxoﬁbrosarcoma  (supra-
poneurotic)  between  2001  and  2010.  All  patients
nderwent  surgery  in  the  same  center  for  all  procedures.
ethods
he  number,  date  and  location  of  recurrences  were  col-
ected  for  each  patient.
This  included  noting  the  size  of  the  largest  nodule  along
ts  longest  axis  at  diagnosis  and  for  each  case  of  recur-
ence.  Depending  upon  the  available  information,  the  size
as  determined  clinically,  on  MRI  and  by  macroscopic  patho-
ogical  assessment  of  the  resected  tumor:
 clinical  measurement  was  obtained  by  the  surgeon  during
the  preoperative  assessment; the  longest  axis  of  the  tumor  was  measured  on  MRI  in  the
following  sequences:  axial,  coronal  and  sagittal  T1  and
T2-weighted  sequences;
i
w macroscopic  pathological  assessment  was  based  on  the
longest  axis  of  the  tumor.
The  tumor  grade,  deﬁned  according  to  the  National  Fed-
ration  for  the  Fight  Against  Cancer  (Fédération  Nationale
e  Lutte  Contre  le  Cancer  [FNCLCC]  [5])  and  the  quality  of
esection  according  to  the  Enneking  classiﬁcation  (intrale-
ional,  marginal,  wide)  [6]  were  obtained  for  each  resected
umor.
he  series
his  series  included  21  patients  (11  women,  10  men),  mean
ge  67  years  old  (38—85)  at  the  ﬁrst  surgical  procedure
Table  1).  The  tumor  was  located  on  the  lower  extremities
n  11  cases  (52%),  upper  extremities  in  eight  cases  (38%)  and
n  the  trunk  in  two  cases  (10%).  A  tumefaction  was  discov-
red  fortuitously  in  all  patients  except  one  who  presented
ith  signs  of  compression  of  the  ulnar  nerve  in  the  elbow.
All  patients  underwent  planned  surgery  whose  goal  was  to
btain  clean  surgical  margins  of  at  least  1  cm.  After  surgery
ll  patients  underwent  postoperative  radiotherapy  at  a  dose
f  between  54  and  60  Grays.  One  patient  also  underwent
eoadjuvant  chemotherapy  due  to  diffuse  subcutaneous  tis-
ue  inﬁltration.
Pathology  results  showed  grade  1  myxoﬁbrosarcomas  in
ve  cases,  grade  2  in  eight  and  grade  3  in  eight  cases.
he  tumor  was  limited  to  the  dermis  and  hypodermis  in  all
ases  (Fig.  1).  Although  resection  seemed  to  be  complete
t  surgery  in  the  21  tumor  samples  that  were  analyzed,  it
as  found  to  be  wide  in  three  cases,  marginal  in  two  cases
nd  intralesional  in  16  cases.  Scar  revision  surgery  was  per-
ormed  in  all  recent  cases  of  intralesional  resection  once  the
athological  results  were  received.
esults
welve  patients  (57%)  presented  with  recurrence,  which  was
lways  local  on  the  periphery  of  the  initial  area  of  resection.
here  were  a  mean  1.4  recurrences  per  patient  (1—8):  in  the
2  patients  with  recurrence,  eight  had  one  or  two  recurren-
es,  two  had  three  recurrences,  and  two  had  four  or  more
ecurrences  (Fig.  2).  Recurrence  occurred  after  a  mean  10.5
onths  (1—29  months).  The  initial  tumor  was  grade  1  in
our  cases,  grade  2  in  four  cases  and  grade  3  in  four  cases.
esected  tumors  from  the  ﬁrst  recurrence  were  one  grade
igher  than  the  initial  tumor  in  58%  of  cases.  In  particular,  inn  100%  of  the  cases.
Two  of  the  patients  with  recurrent  tumors  presented
ith  distant  metastases  associated  with  the  recurrent  tumor
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Table  1  Clinical  features  of  the  21  patients.
Age  Gender  Tumor  location  Surgical  margin  Grade  Number  of  recurrences  Metastases
1  38  F  Buttocks  R2  1  0  No
2 59  F  Knee  R1  3  0  No
3 80  F  Popliteal  fossa  R2  2  0  No
4 81  F  Back  R2  2  2  No
5 62  M  Leg  R0  3  0  No
6 57  F  3rd  ﬁnger  R2  3  0  No
7 43  F  Forearm  R2  3  3  Lungs,  liver,  bone
8 76  M  Forearm  R2  2  1  No
9 59  M  Back  R2  1  1  No
10 77  M  Knee R2  2  0  No
11 57  M  Leg  R1  1  1  No
12 67  F  Forearm  R2  1  3  No
13 68  M  Arm  R2  3  4  No
14 73  F  Leg  R0  2  0  No
15 67  F  Leg  R2  1  2  No
16 61  M  Leg  R0  2  8  No
17 60  F  Knee  R2  2  0  No
18 70  M  Shoulder  R2  3  1  Lungs,  liver
19 79  M  Leg  R2  3  2  No
20 85  M  Arm  R2  3  0  No
21 67  F  Wrist  R2  2  1  No
: ma
i
w
s
7
pR0: absence of residual tumor; R1: microscopic tumor remains; R2
(pulmonary,  liver  and  bone).  They  were  discovered  during
the  ﬁrst  recurrence  in  one  case  and  the  third  in  the  other
case.  The  latter  died  6  months  after  the  last  surgical  proce-
dure  for  recurrence  and  the  discovery  of  metastases.  These
patients  received  adjuvant  chemotherapy  as  well  as  revision
surgery.
The  surgical  margins  were  wide  in  4/21  patients,
marginal  in  2  and  intralesional  in  15  cases  and  recurrence
occurred  in  25,  50  and  67%  respectively.  The  surgical  margins
Figure  1  Myxoﬁbrosarcoma  of  the  leg.  Sagittal  T2-weighted
MRI with  comet  tail  appearance.
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n  the  29  other  tumor  samples,  resected  due  to  recurrence,
ere  wide  in  seven  cases,  marginal  in  two  cases  and  intrale-
ional  in  20  cases  with  a rate  of  new  recurrence  of  14,  50  and
5%  respectively.  Out  of  the  total  of  50  resected  tumor  sam-
les  (including  initial  and  recurrent  tumors),  recurrence  was
8,  50  and  71%  respectively.
The  results  of  this  series  were  not  inﬂuenced  by  histolog-
cal  grade  or  age.  The  rate  of  recurrence  in  relation  to  the
istological  grade  was  80,  50  and  50%  for  grades  1,  2  and  3
espectively.  The  mean  age  of  patients  with  recurrence  was
6.2  and  of  those  without  was  65.6.
valuation of tumor sizelinical  measurement  of  the  longest  axis  of  the  main  nod-
le  was  available  retrospectively  in  14  of  the  tumor  samples
nd  a  preoperative  MRI  was  available  in  ﬁve  cases.  Clinical
igure  2  Number  of  patients  in  relation  to  the  number  of
ecurrences.
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Figure  3  Myxoﬁbrosarcoma  of  the  leg.  Clinical  appearance
and MRI  features.
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that  surgical  margins  are  wide  enough.Figure  4  Macroscopic  view  of  resected  tumor.
easurement  was  underestimated  a  by  a  mean  2.4  cm
0—11)  compared  to  macroscopic  pathology  results.  The
RI  measurement  was  also  underestimated  by  a  mean
.3  cm  (0—7.7)  compared  to  macroscopic  pathology  results
Figs.  3  and  4).
iscussion
or  several  years  certain  authors  have  deﬁned  myxoﬁbrosar-
omas  as  a  distinct  tumoral  entity  [7].  This  entity  has  been
ecognized  since  2002  and  is  now  included  in  the  World
ealth  Organization  tumor  classiﬁcation  [8].
Myxoﬁbrosarcomas  are  one  of  the  most  frequent  sarco-
as  in  the  elderly  with  a  peak  incidence  in  patients  between
1  and  70  years  old  [9].  They  are  usually  located  on  the  lower
xtremities.  These  are  malignant  connective  tissue  tumors
nvolving  cutaneous  and  subcutaneous  tissue  in  two  thirds  of
he  cases.  In  other  cases  the  fascia,  underlying  muscles  and
ven  the  bone  may  be  involved.  Angervall  et  al.  reported
ocal  recurrence  in  50—60%  of  cases,  with  no  relationship  to
istological  grade  [7].
t
eG.  Riouallon  et  al.
On  the  other  hand  Willems  et  al.  [1], in  a  series  of  32
yxoﬁbrosarcomas  and  Fukunaga  and  Fukunaga  [10]  in  the
athological  assessment  of  one  case,  have  already  shown
hat  low-grade  tumors  frequently  increase  in  grade  during
ocal  recurrence  and  may  metastasize.  For  Ferguson  et  al.,
 diagnosis  of  myxoﬁbrosarcoma  may  even  be  predictive  of
n  increase  in  histological  grade  during  any  eventual  recur-
ence  [11]. We  reached  the  same  conclusions  since  58%  of
ecurrences  were  a  grade  higher  than  that  of  the  initial
umor  and  two  patients  presented  with  distant  metastases.
evertheless,  because  of  the  small  number  of  patients  it  was
ot  possible  to  show  any  correlation  between  the  progres-
ion  of  tumor  aggressivity  and  the  number  of  recurrences.
Myxoﬁbrosarcomas  are  characterized  by  their  signiﬁcant
ultidirectional  spreading  pattern  along  the  fascial  planes
9,12,13]. This  is  seen  as  a  hypersignal  on  T2-weighted  MR
mages  which  usually  has  a  comet  tail  appearance,  and  which
as  been  clearly  described  by  Kaya  et  al.  [4].  According  to
hese  authors,  this  characteristic  inﬁltration  is  found  in  80%
f  the  cases  of  myxoﬁbrosarcoma.  Nevertheless  the  hyper-
ignal  on  T2-weighted  images  is  not  constant:  in  a  certain
umber  of  cases,  MRI  shows  a  local  lesion  and  spreading
long  the  fascias  is  identiﬁed  by  histological  analysis  of  the
umor  sample.  This  probably  explains  the  high  rate  of  con-
aminated  or  marginal  surgical  margins  in  resected  tumors
78%  of  the  primary  tumors  and  recurrent  tumors  in  our
eries).
Our  rate  of  recurrence  (57%)  is  comparable  to  that
eported  in  the  literature:  52—61%  [2,7,9,12,14].  For  Merk
t  al.  [12]  the  rate  of  recurrence  may  be  inﬂuenced  by  age
more  recurrence  in  elderly  patients),  histological  grade  and
he  quality  of  resection  [15,16].  In  our  series,  as  in  others
15—19],  the  rate  of  recurrence  logically  varied  in  relation
o  the  quality  of  the  surgical  margins.  On  the  other  hand
nlike  Lin  et  al.  [15]  and  Gronchi  et  al.  [16], we  did  not  ﬁnd
ny  correlation  with  the  histological  grade,  which  has  also
een  noted  by  several  authors  [18—23].  Age  was  also  not  a
actor  that  inﬂuenced  the  rate  of  recurrence  (65.6  vs.  66.2).
Nevertheless  there  are  two  important  observations  in  our
tudy.  First,  the  signiﬁcant  difference  in  the  rate  of  recur-
ence  between  wide  and  contaminated  surgical  margins  (18
s.  71%),  which  emphasizes  the  importance  of  obtaining  the
ost  complete  resection  possible  at  the  outset  (the  high
ate  of  recurrence  even  with  wide  margins  should  be  noted
18%]).  Myxoﬁbrosarcomas  are  therefore  difﬁcult  tumors  to
ontrol  even  when  appropriate  treatment  is  provided.  At
he  same  time  it  is  impossible  to  establish  a statistical  cor-
elation  between  the  quality  of  the  surgical  margins  and
ecurrence  in  this  study  for  two  reasons.  First  this  tumor
s  rare,  therefore  there  were  very  few  patients  included  in
he  study,  making  it  impossible  to  obtain  a  correlation.  Sec-
nd,  surgical  management  of  marginal  resection  changed
etween  2001  and  2010:  initially  patients  did  not  systemat-
cally  undergo  revision  surgery  if  pathology  results  showed
esection  to  be  marginal,  while  this  is  now  systematic.  These
bservations  are  a  reminder  of  how  important  the  ﬁrst
iopsy  is;  when  the  diagnosis  of  myxoﬁbrosarcoma  is  con-
rmed,  particular  attention  should  be  paid  to  making  sureNormally  T2-weighted  MRI  is  the  best  technique  to  iden-
ify  the  extent  of  tumoral  invasion.  At  the  same  time,  Kaya
t  al.  [4]  have  shown  that  MRI  is  not  sufﬁcient  to  identify
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tumoral  inﬁltration  in  these  cases.  We  reached  the  same
conclusions  in  our  study,  which  showed  that  the  size  of  the
tumor  was  underestimated  by  a  mean  1.3  cm  on  MRI  com-
pared  to  pathology  results.  However,  there  were  not  enough
MRIs  in  our  study  to  deﬁne  a  safe  surgical  margin  that  ensures
that  healthy  tissue  has  been  reached.  Our  results  do  not
provide  more  information  on  this  issue  than  the  study  by
Kaya  et  al.  [4]  who  recommend  resection  of  all  of  the  tissue
with  a  hypersignal.  To  determine  the  ideal  surgical  margins,
a  study  would  have  to  be  performed  to  evaluate  tumor  size
with  MRI  and  on  pathology,  which  is  difﬁcult  because  of  the
low  incidence  of  this  tumor.
Conclusion
It  is  difﬁcult  to  obtain  complete  resection  of  superﬁcial
myxoﬁbrosarcomas  during  the  initial  surgical  procedure,
because  the  invasive  spreading  of  these  tumors  is  often  undi-
agnosed  before  surgery.  This  tumor  should  be  resected  as
completely  as  possible  during  the  ﬁrst  surgical  procedure
because  of  the  high  risk  of  recurrence.  Thus,  surgical  treat-
ment  of  these  tumors  must  include  surgical  margins  that  are
much  wider  than  those  suggested  by  the  clinical  evaluation
and  MRI.  It  is  therefore  important  to  perform  a  biopsy  ﬁrst  to
conﬁrm  the  diagnosis  and  plan  on  wide  resection.  Indeed  in
many  cases,  tumor  inﬁltration  identiﬁed  on  T2-weighted  MRI
sequences  underestimated  actual  tumoral  inﬁltration.  Even
after  complete  resection,  the  risk  of  recurrence  is  high.  In
case  of  marginal  or  incomplete  resection,  revision  surgery
of  the  scar  should  be  systematically  performed.
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